{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T09:01:40Z","timestamp":1794819700541,"version":"4.9.1"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Acute type A aortic dissection (ATAAD) has a high mortality, and acute aortic repair is the only curative treatment. In patients treated with factor Xa (FXa) inhibitors, the risk of severe disease-related complications such as cardiac tamponade and hemodynamic shock must be balanced against the potential for severe perioperative bleeding. The aim was to study intraoperative changes in plasma levels of the FXa inhibitor apixaban when using hemoadsorption during acute thoracic aortic repair.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods:<\/jats:title>\n            <jats:p>This is a single-center prospective cohort study. Eight apixaban-treated patients presenting with ATAAD underwent acute thoracic aortic repair with intraoperative hemoadsorption with CytoSorb. Apixaban concentrations were measured at the start of cardiopulmonary bypass (CPB) and after 5, 15, 30, 60, and 90\u00a0min of CPB, at CPB weaning, 30\u00a0min after CPB weaning and 24\u00a0h postoperatively, using ultraperformance liquid chromatography\u2013mass spectrometry (UPLC-MS).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>After 30\u00a0min of CPB with hemoadsorption, mean apixaban concentration (\u00b1SD) was reduced by 59% from 108 (\u00b169)\u00a0\u00b5g\/l to 44 (\u00b120)\u00a0\u00b5g\/l (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.009). There was a further reduction to 37 (\u00b117)\u00a0\u00b5g\/l at CPB weaning (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.008). Apixaban concentration displayed an increase to 56 (\u00b129)\u00a0\u00b5g\/l 24\u00a0h postoperatively (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.01). In-hospital mortality was 25%. The mean 24H chest tube drainage volume was 621 (\u00b1136)\u00a0ml.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Intraoperative hemoadsorption lowers apixaban levels in patients undergoing emergency surgery for ATAAD. Further research is needed to determine its impact on perioperative bleeding complications and mortality.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/js9.0000000000002137","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T12:01:34Z","timestamp":1731931294000},"page":"7782-7790","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Apixaban removal during emergency surgery for type A acute aortic dissection: a prospective cohort study"],"prefix":"10.1097","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7412-4554","authenticated-orcid":false,"given":"Henriette","family":"R\u00f8ed-Undlien","sequence":"first","affiliation":[{"name":"Institute of Clinical Medicine, University of Oslo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9194-4952","authenticated-orcid":false,"given":"Nina H.","family":"Schultz","sequence":"additional","affiliation":[{"name":"Research Institute for Internal Medicine, Oslo University Hospital"},{"name":"Department of Hematology, Oslo University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger M.","family":"Husebr\u00e5ten","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Oslo University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7261-275X","authenticated-orcid":false,"given":"Birgit M.","family":"Wollmann","sequence":"additional","affiliation":[{"name":"Center for Psychopharmacology, Diakonhjemmet Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupali R.","family":"Akerkar","sequence":"additional","affiliation":[{"name":"Department of Health Registries, Norwegian Institute of Public Health, Bergen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6190-2751","authenticated-orcid":false,"given":"Espen","family":"Molden","sequence":"additional","affiliation":[{"name":"Center for Psychopharmacology, Diakonhjemmet Hospital"},{"name":"Department of Pharmacy, Section for Pharmacology and Pharmaceutical Biosciences, University of Oslo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6323-9559","authenticated-orcid":false,"given":"Erik K.","family":"Amundsen","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Oslo University Hospital"},{"name":"Department of Life Sciences and Health, Oslo Metropolitan University, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9031-342X","authenticated-orcid":false,"given":"Johannes L.","family":"Bj\u00f8rnstad","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, University of Oslo"},{"name":"Department of Cardiothoracic Surgery, Oslo University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12]]},"reference":[{"key":"R1-20250824","doi-asserted-by":"crossref","first-page":"e2328033","DOI":"10.1001\/jamanetworkopen.2023.28033","article-title":"Clinical outcomes of direct oral anticoagulants vs warfarin for extended treatment of venous thromboembolism","volume":"6","author":"Fang","year":"2023","journal-title":"JAMA Network Open"},{"key":"R2-20250824","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"R3-20250824","doi-asserted-by":"crossref","first-page":"k2505","DOI":"10.1136\/bmj.k2505","article-title":"Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care","volume":"362","author":"Vinogradova","year":"2018","journal-title":"BMJ"},{"key":"R5-20250824","doi-asserted-by":"crossref","first-page":"e001278","DOI":"10.1136\/openhrt-2020-001278","article-title":"Operative survival in patients with acute aortic disease in the era of newer oral anticoagulants","volume":"7","author":"Bj\u00f8rnstad","year":"2020","journal-title":"Open Heart"},{"key":"R6-20250824","doi-asserted-by":"crossref","first-page":"ivac037","DOI":"10.1093\/icvts\/ivac037","article-title":"Prior intake of new oral anticoagulants adversely affects outcome following surgery for acute type A aortic dissection","volume":"35","author":"Sromicki","year":"2022","journal-title":"Interact Cardiovasc and Thorac Surg"},{"issue":"Suppl_1","key":"R7-20250824","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1182\/blood-2019-125955","article-title":"Administration of andexanet alfa for direct factor Xa inhibitor reversal precludes therapeutic heparinization for cardiopulmonary bypass","volume":"134","author":"Thalji","year":"2019","journal-title":"Blood"},{"key":"R8-20250824","first-page":"390","article-title":"Difficult intraoperative heparinization following andexanet alfa administration","volume":"3","author":"Watson","year":"2019","journal-title":"Clin Pract Cases Emerg Med"},{"key":"R9-20250824","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"key":"R10-20250824","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/jamacardio.2022.2718","article-title":"Early mortality in type A acute aortic dissection: insights from the international registry of acute aortic dissection","volume":"7","author":"Harris","year":"2022","journal-title":"JAMA Cardiol"},{"key":"R11-20250824","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1161\/CIRCULATIONAHA.122.061065","article-title":"Clinical characteristics, incidences, and mortality rates for type A and B aortic dissections: a nationwide Danish population-based cohort study from 1996 to 2016","volume":"146","author":"Obel","year":"2022","journal-title":"Circulation"},{"key":"R12-20250824","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13019-017-0613-5","article-title":"Consumption coagulopathy in acute aortic dissection: principles of management","volume":"12","author":"Liu","year":"2017","journal-title":"J Cardiothorac Surg"},{"key":"R13-20250824","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.athoracsur.2017.11.066","article-title":"Bleeding complications after use of novel oral anticoagulants in patients undergoing cardiac surgery","volume":"105","author":"Hassan","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"R14-20250824","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5761\/atcs.oa.21-00154","article-title":"Hemoadsorption of rivaroxaban and ticagrelor during acute type A aortic dissection operations","volume":"28","author":"Hassan","year":"2022","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"R15-20250824","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.athoracsur.2018.12.032","article-title":"Cytosorb adsorption during emergency cardiac operations in patients at high risk of bleeding","volume":"108","author":"Hassan","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"R16-20250824","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s12055-021-01183-4","article-title":"The effect of hemoadsorption on rivaroxaban blood plasma concentration in emergency cardiac surgery","volume":"37","author":"Kr\u00fcger","year":"2021","journal-title":"Indian J Thorac Cardiovasc Surg"},{"key":"R17-20250824","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1053\/j.jvca.2022.01.038","article-title":"In vitro apixaban removal by CytoSorb whole blood adsorber: an experimental study","volume":"36","author":"R\u00f8ed-Undlien","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R18-20250824","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1111\/jcpt.13802","article-title":"CytoSorb haemoadsorption for removal of apixaban\u2014a proof-of-concept pilot case for a randomized controlled trial","volume":"47","author":"Buonocore","year":"2022","journal-title":"J Clin Pharm Ther"},{"key":"R19-20250824","first-page":"2","article-title":"Apixaban blood levels reduced by the use of Cytosorb added to cardiopulmonary bypass","volume":"51","author":"Nardi","year":"2022","journal-title":"Blood Purif"},{"key":"R20-20250824","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s40140-021-00511-z","article-title":"Perioperative guidelines on antiplatelet and anticoagulant agents: 2022 update","volume":"12","author":"Moster","year":"2022","journal-title":"Curr Anesthesiol Rep"},{"key":"R21-20250824","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/jth.13227","article-title":"When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH","volume":"14","author":"Levy","year":"2016","journal-title":"J Thromb Haemost"},{"key":"R22-20250824","doi-asserted-by":"crossref","first-page":"106165","DOI":"10.1016\/j.ijsu.2021.106165","article-title":"STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case\u2013control studies in surgery","volume":"96","author":"Mathew","year":"2021","journal-title":"Int J Surg"},{"key":"R24-20250824","first-page":"1118","article-title":"Dissection and dissecting aneurysms of the aorta: twenty-year follow-up of five hundred twenty-seven patients treated surgically","volume":"92","author":"DeBakey","year":"1982","journal-title":"Surgery"},{"key":"R25-20250824","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13019-021-01594-9","article-title":"Surgical outcomes of DeBakey type I and type II acute aortic dissection: a propensity score-matched analysis in 599 patients","volume":"16","author":"Lin","year":"2021","journal-title":"J Cardiothorac Surg"},{"key":"R26-20250824","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1161\/CIRCULATIONAHA.113.001875","article-title":"Outcomes of urgent warfarin reversal with frozen plasma versus prothrombin complex concentrate in the emergency department","volume":"128","author":"Hickey","year":"2013","journal-title":"Circulation"},{"key":"R27-20250824","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jtcvs.2004.06.028","article-title":"Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery","volume":"129","author":"Karkouti","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R28-20250824","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1053\/j.jvca.2017.04.014","article-title":"Hemodilution on cardiopulmonary bypass: thromboelastography patterns and coagulation-related outcomes","volume":"31","author":"Ranucci","year":"2017","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R29-20250824","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2110-5820-1-2","article-title":"Perioperative fluid and volume management: physiological basis, tools and strategies","volume":"1","author":"Strunden","year":"2011","journal-title":"Ann Intensive Care"},{"key":"R30-20250824","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1814051","article-title":"Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors","volume":"380","author":"Connolly","year":"2019","journal-title":"N Engl J Med"},{"key":"R31-20250824","doi-asserted-by":"crossref","first-page":"13908","DOI":"10.1038\/s41598-021-93372-9","article-title":"Apixaban concentration variability and relation to clinical outcomes in real-life patients with atrial fibrillation","volume":"11","author":"Mavri","year":"2021","journal-title":"Sci Rep"},{"key":"R32-20250824","doi-asserted-by":"crossref","first-page":"17","DOI":"10.21037\/aob.2019.07.01","article-title":"Clinical use and laboratory testing of oral anticoagulation therapy: experience from Finland","volume":"4","author":"Helin","year":"2019","journal-title":"Ann Blood"},{"key":"R33-20250824","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1253\/circj.CJ-18-1282","article-title":"Rivaroxaban or apixaban for non-valvular atrial fibrillation - efficacy and safety of off-label under-dosing according to plasma concentration","volume":"83","author":"Suwa","year":"2019","journal-title":"Circ J"},{"key":"R34-20250824","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1038\/psp.2014.34","article-title":"Model-based exposure-response analysis of apixaban to quantify bleeding risk in special populations of subjects undergoing orthopedic surgery","volume":"3","author":"Leil","year":"2014","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"R35-20250824","doi-asserted-by":"crossref","first-page":"100699","DOI":"10.1016\/j.xkme.2023.100699","article-title":"Apixaban dosing in patients with kidney failure treated with peritoneal dialysis","volume":"5","author":"Lidgard","year":"2023","journal-title":"Kidney Med"},{"key":"R36-20250824","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.jvca.2011.09.021","article-title":"Increased chest tube drainage is independently associated with adverse outcome after cardiac surgery","volume":"26","author":"Christensen","year":"2012","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R37-20250824","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1537-2995.2012.03697.x","article-title":"The association of blood transfusion with mortality after cardiac surgery: cause or confounding? (CME)","volume":"53","author":"Dixon","year":"2013","journal-title":"Transfusion"},{"key":"R38-20250824","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.3390\/jcm11195889","article-title":"Removal of apixaban during emergency cardiac surgery using hemoadsorption with a porous polymer bead sorbent","volume":"11","author":"Hassan","year":"2022","journal-title":"J Clin Med"},{"key":"R39-20250824","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s11239-024-02996-x","article-title":"Intraoperative haemoadsorption for antithrombotic drug removal during cardiac surgery: initial report of the international safe and timely antithrombotic removal (STAR) registry","volume":"57","author":"Schmoeckel","year":"2024","journal-title":"J Thromb Thrombolysis"},{"key":"R40-20250824","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1053\/j.jvca.2019.02.013","article-title":"The coagulopathy of acute type A aortic dissection: a prospective, observational study","volume":"33","author":"Zindovic","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R41-20250824","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3390\/jcm12020546","article-title":"Intraoperative hemoadsorption (Cytosorb\u2122) during open thoracoabdominal aortic repair: a pilot randomized controlled trial","volume":"12","author":"Doukas","year":"2023","journal-title":"J Clin Med"},{"key":"R42-20250824","doi-asserted-by":"crossref","first-page":"ezad340","DOI":"10.1093\/ejcts\/ezad340","article-title":"Optimal management of cardiac surgery patients using direct oral anticoagulants: recommendations for clinical practice","volume":"64","author":"Heuts","year":"2023","journal-title":"Eur J Cardiothorac Surg"},{"key":"R43-20250824","first-page":"CD013551","article-title":"Prothrombin complex concentrate in cardiac surgery for the treatment of coagulopathic bleeding","volume":"11","author":"Hayes","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"R44-20250824","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1111\/jth.13815","article-title":"Reversal of apixaban anticoagulation by four-factor prothrombin complex concentrates in healthy subjects: a randomized three-period crossover study","volume":"15","author":"Song","year":"2017","journal-title":"J Thromb Haemost"},{"key":"R45-20250824","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12959-017-0129-1","article-title":"The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor","volume":"15","author":"Schultz","year":"2017","journal-title":"Thromb J"},{"key":"R46-20250824","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/14779072.2022.2074838","article-title":"The use of FEIBA for refractory bleeding in cardiac surgery - a systematic review","volume":"20","author":"Khoury","year":"2022","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R47-20250824","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/phar.2306","article-title":"Intraoperative unfractionated heparin unresponsiveness during endovascular repair of a ruptured abdominal aortic aneurysm following administration of andexanet alfa for the reversal of rivaroxaban","volume":"39","author":"Eche","year":"2019","journal-title":"Pharmacotherapy"},{"key":"R48-20250824","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11239-019-01973-z","article-title":"Cost comparison of andexanet versus prothrombin complex concentrates for direct factor Xa inhibitor reversal after hemorrhage","volume":"49","author":"Frontera","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"R49-20250824","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/STROKEAHA.120.031108","article-title":"Economic evaluation of andexanet versus prothrombin complex concentrate for reversal of factor Xa-associated intracranial hemorrhage","volume":"52","author":"Micieli","year":"2021","journal-title":"Stroke"},{"key":"R50-20250824","first-page":"366","article-title":"Hemoadsorption using CytoSorb(\u00ae) in patients with infective endocarditis: a German-based budget impact analysis","volume":"10","author":"Rao","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"key":"R52-20250824","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11239-022-02706-5","article-title":"Safety and efficacy of fibrinogen concentrate in aortic arch surgery involving moderate hypothermic circulatory arrest","volume":"55","author":"Guan","year":"2023","journal-title":"J Thromb Thrombolysis"},{"key":"R53-20250824","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/anae.14842","article-title":"The role of fibrinogen and fibrinogen concentrate in cardiac surgery: an international consensus statement from the Haemostasis and Transfusion Scientific Subcommittee of the European Association of Cardiothoracic Anaesthesiology","volume":"74","author":"Erdoes","year":"2019","journal-title":"Anaesthesia"},{"key":"R54-20250824","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ajem.2017.10.001","article-title":"The relationship between fibrinogen and in-hospital mortality in patients with type A acute aortic dissection","volume":"36","author":"Liu","year":"2018","journal-title":"Am J Emerg Med"},{"key":"R55-20250824","first-page":"498","article-title":"Predictors and impact of massive bleeding in acute type A aortic dissection","volume":"24","author":"Zindovic","year":"2017","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R56-20250824","doi-asserted-by":"crossref","first-page":"676","DOI":"10.7326\/0003-4819-121-9-199411010-00009","article-title":"Interactions of warfarin with drugs and food","volume":"121","author":"Wells","year":"1994","journal-title":"Ann Intern Med"},{"key":"R57-20250824","doi-asserted-by":"crossref","first-page":"ezad426","DOI":"10.1093\/ejcts\/ezad426","article-title":"EACTS\/STS Guidelines for diagnosing and treating acute and chronic syndromes of the aortic organ","volume":"65","author":"Czerny","year":"2024","journal-title":"Eur J Cardiothorac Surg"},{"key":"R58-20250824","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1053\/j.semtcvs.2019.05.006","article-title":"Hemoadsorption to reduce plasma-free hemoglobin during cardiac surgery: results of REFRESH I pilot study","volume":"31","author":"Gleason","year":"2019","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"R59-20250824","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s40262-019-00775-z","article-title":"Apixaban: a clinical pharmacokinetic and pharmacodynamic review","volume":"58","author":"Byon","year":"2019","journal-title":"Clin Pharmacokinet"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000002137","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T19:18:11Z","timestamp":1756063091000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000002137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":56,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000002137","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"assertion":[{"value":"2024-08-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}